Matteo Cereda

发表

Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1

Francesca D. Ciccarelli, Matteo Cereda, F. Ciccarelli, 2017, Oncotarget.

Identification of altered biological processes in heterogeneous RNA-sequencing data by discretization of expression profiles

M. D. Giudice, P. Rajan, Matteo Cereda, 2019, Nucleic acids research.

Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

J. Ule, M. Kayikci, T. Hortobágyi, 2011, Nature neuroscience.

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma

C. Yau, S. Tavaré, A. Hindmarsh, 2019, Nature Communications.

Patient-specific detection of cancer genes reveals recurrently perturbed processes in esophageal adenocarcinoma

C. Yau, F. Ciccarelli, R. Fitzgerald, 2018, bioRxiv.

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond

Matteo Cereda, F. Fagioli, K. Mareschi, 2021, Cells.

Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas

A. De Grassi, F. Ciccarelli, A. Viel, 2014, Genome Biology.

Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes

F. Ciccarelli, Lorena Benedetti, Matteo Cereda, 2016, Nature Communications.

Recessive cancer genes engage in negative genetic interactions with their functional paralogs.

F. Ciccarelli, P. P. Di Fiore, Matteo Cereda, 2013, Cell reports.

Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

J. Ule, M. Kayikci, T. Hortobágyi, 2011, Nature neuroscience.

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

A. Naccarati, A. Sapino, S. Bellomo, 2022, Genome Medicine.

FOXA1 regulates alternative splicing in prostate cancer

M. Del Giudice, S. Guarrera, P. Rajan, 2022, Cell reports.

A Comprehensive Bioinformatics Analysis of UBE2C in Cancers

Matteo Cereda, S. Oliviero, H. Dastsooz, 2019, International journal of molecular sciences.

Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas

A. De Grassi, F. Ciccarelli, A. Viel, 2014, Genome Biology.

Molecular Characterization of Prostate Cancers in the Precision Medicine Era

G. Banna, Matteo Cereda, E. Bollito, 2021, Cancers.

Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases

J. Ule, M. Kayikci, T. Hortobágyi, 2011, Nature Neuroscience.

Both selective and neutral processes drive GC content evolution in the human genome

Matteo Fumagalli, Uberto Pozzoli, Matteo Cereda, 2008, BMC Evolutionary Biology.

Omic approaches to pediatric bone sarcomas

Matteo Cereda, F. Fagioli, S. Asaftei, 2019, Pediatric blood & cancer.

Artificial Intelligence in Bulk and Single-Cell RNA-Sequencing Data to Foster Precision Oncology

M. Del Giudice, Matteo Cereda, F. Fagioli, 2021, International journal of molecular sciences.

Dysregulation of splicing-related proteins in prostate cancer is controlled by FOXA1

N. Lemoine, P. Rajan, Matteo Cereda, 2018 .

Gene function and expression level influence the insertion/fixation dynamics of distinct transposon families in mammalian introns

N. Bresolin, G. Comi, R. Cagliani, 2006, Genome Biology.

GeCo++: a C++ library for genomic features computation and annotation in the presence of variants

Matteo Cereda, Uberto Pozzoli, Matteo Cavalleri, 2011, Bioinform..

RNAmotifs: prediction of multivalent RNA motifs that control alternative splicing

Tyson A. Clark, J. Ule, A. Schweitzer, 2014, Genome Biology.

MEGA-V: detection of variant gene sets in patient cohorts

Francesca D. Ciccarelli, Gennaro Gambardella, Matteo Cereda, 2016, Bioinform..

Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors

A. Sapino, B. Pasini, M. Aglietta, 2022, npj Precision Oncology.

Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing

N. Bresolin, G. Comi, S. Corti, 2011, BMC Medical Genetics.

HNRNPA2B1 controls an unfolded protein response-related prognostic gene signature in prostate cancer

C. Bessant, P. Rajan, H. Leung, 2022, bioRxiv.

Genetic Redundancy, Functional Compensation, and Cancer Vulnerability.

F. Ciccarelli, Matteo Cereda, T. Mourikis, 2016, Trends in cancer.

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma

C. Yau, F. Ciccarelli, R. Fitzgerald, 2019, Nature Communications.

HaTSPiL: A modular pipeline for high-throughput sequencing data analysis

Matteo Cereda, Silvia Deaglio, Danny Incarnato, 2019, PloS one.